Positive results from canine pharmacokinetic study demonstrate up to three-fold increase in antibody half-life. Longer half-lives have the potential to reduce dosing frequency, lower doses, and/or reduce cost of goods sold. Technology expected to lead to multiple best-in-class products. San Francisco, California (January 8, 2020) – Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company […]
Be part of the Transformation in veterinary medicine
We love the pets around us – our dogs, cats, and horses we share our lives with. Many of us believe these animals are part of the family, providing us unconditional love and companionship throughout our lives. We have an opportunity for cutting edge treatment when disease and chronic conditions cross our path, but what happens when our animal companions encounter these same issues?